Baidu
map
BIOMEDICINES 润色咨询

Biomedicines

出版年份：暂无数据 年文章数：3690 投稿命中率： 开通期刊会员，数据随心看

出版周期：Q 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2231345, encodeId=d5ba223134586, content=Pending大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6dd9470622, createdName=ms3000001950019838, createdTime=Thu Oct 17 13:49:49 CST 2024, time=2024-10-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2229966, encodeId=a265222996642, content=偏重的研究方向：肿瘤;药学<br>经验分享：大修只给 10 天😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Oct 09 15:16:44 CST 2024, time=2024-10-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229785, encodeId=bcd22229e85bb, content=各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Oct 08 12:52:03 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学<br>经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的 被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学<br>经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：miRNAs;cancer;Bioinformatics<br>经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省)]
    2024-10-17 ms3000001950019838 来自湖北省

    Pending大概多久呢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2231345, encodeId=d5ba223134586, content=Pending大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6dd9470622, createdName=ms3000001950019838, createdTime=Thu Oct 17 13:49:49 CST 2024, time=2024-10-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2229966, encodeId=a265222996642, content=偏重的研究方向：肿瘤;药学<br>经验分享：大修只给 10 天😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Oct 09 15:16:44 CST 2024, time=2024-10-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229785, encodeId=bcd22229e85bb, content=各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Oct 08 12:52:03 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学<br>经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的 被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学<br>经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：miRNAs;cancer;Bioinformatics<br>经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省)]
    2024-10-09 ms4000001640011867 来自福建省

    偏重的研究方向：肿瘤;药学
    经验分享：大修只给 10 天😵‍💫

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2231345, encodeId=d5ba223134586, content=Pending大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6dd9470622, createdName=ms3000001950019838, createdTime=Thu Oct 17 13:49:49 CST 2024, time=2024-10-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2229966, encodeId=a265222996642, content=偏重的研究方向：肿瘤;药学<br>经验分享：大修只给 10 天😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Oct 09 15:16:44 CST 2024, time=2024-10-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229785, encodeId=bcd22229e85bb, content=各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Oct 08 12:52:03 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学<br>经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的 被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学<br>经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：miRNAs;cancer;Bioinformatics<br>经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省)]
    2024-10-08 隔壁李叔叔 来自江苏省

    各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2231345, encodeId=d5ba223134586, content=Pending大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6dd9470622, createdName=ms3000001950019838, createdTime=Thu Oct 17 13:49:49 CST 2024, time=2024-10-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2229966, encodeId=a265222996642, content=偏重的研究方向：肿瘤;药学<br>经验分享：大修只给 10 天😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Oct 09 15:16:44 CST 2024, time=2024-10-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229785, encodeId=bcd22229e85bb, content=各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Oct 08 12:52:03 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学<br>经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的 被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学<br>经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：miRNAs;cancer;Bioinformatics<br>经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省)]
    2024-09-11 ms4000001640011867 来自福建省

    偏重的研究方向：肿瘤;药学
    经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2231345, encodeId=d5ba223134586, content=Pending大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6dd9470622, createdName=ms3000001950019838, createdTime=Thu Oct 17 13:49:49 CST 2024, time=2024-10-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2229966, encodeId=a265222996642, content=偏重的研究方向：肿瘤;药学<br>经验分享：大修只给 10 天😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Oct 09 15:16:44 CST 2024, time=2024-10-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229785, encodeId=bcd22229e85bb, content=各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Oct 08 12:52:03 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学<br>经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的 被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学<br>经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：miRNAs;cancer;Bioinformatics<br>经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省)]
    2024-05-21 biocell160 来自贵州省

    不是很快嘛，pending review一般多久啊

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2231345, encodeId=d5ba223134586, content=Pending大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6dd9470622, createdName=ms3000001950019838, createdTime=Thu Oct 17 13:49:49 CST 2024, time=2024-10-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2229966, encodeId=a265222996642, content=偏重的研究方向：肿瘤;药学<br>经验分享：大修只给 10 天😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Oct 09 15:16:44 CST 2024, time=2024-10-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229785, encodeId=bcd22229e85bb, content=各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Oct 08 12:52:03 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学<br>经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的 被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学<br>经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：miRNAs;cancer;Bioinformatics<br>经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省)]
    2024-07-21 ms5000000105524119 来自广西

    😭第一作者是医院的 被模版拒了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2231345, encodeId=d5ba223134586, content=Pending大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6dd9470622, createdName=ms3000001950019838, createdTime=Thu Oct 17 13:49:49 CST 2024, time=2024-10-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2229966, encodeId=a265222996642, content=偏重的研究方向：肿瘤;药学<br>经验分享：大修只给 10 天😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Oct 09 15:16:44 CST 2024, time=2024-10-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229785, encodeId=bcd22229e85bb, content=各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Oct 08 12:52:03 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学<br>经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的 被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学<br>经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：miRNAs;cancer;Bioinformatics<br>经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省)]
    2024-07-05 ms5000000105524119 来自广西

    偏重的研究方向：药学
    经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2231345, encodeId=d5ba223134586, content=Pending大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6dd9470622, createdName=ms3000001950019838, createdTime=Thu Oct 17 13:49:49 CST 2024, time=2024-10-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2229966, encodeId=a265222996642, content=偏重的研究方向：肿瘤;药学<br>经验分享：大修只给 10 天😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Oct 09 15:16:44 CST 2024, time=2024-10-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229785, encodeId=bcd22229e85bb, content=各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Oct 08 12:52:03 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学<br>经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的 被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学<br>经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：miRNAs;cancer;Bioinformatics<br>经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省)]
    2024-04-23 ms4000000323459199 来自江苏省

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：不难

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2231345, encodeId=d5ba223134586, content=Pending大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6dd9470622, createdName=ms3000001950019838, createdTime=Thu Oct 17 13:49:49 CST 2024, time=2024-10-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2229966, encodeId=a265222996642, content=偏重的研究方向：肿瘤;药学<br>经验分享：大修只给 10 天😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Oct 09 15:16:44 CST 2024, time=2024-10-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229785, encodeId=bcd22229e85bb, content=各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Oct 08 12:52:03 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学<br>经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的 被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学<br>经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：miRNAs;cancer;Bioinformatics<br>经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省)]
    2021-09-14 1de65763m65(暂无匿称)

    审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0
    偏重的研究方向：miRNAs;cancer;Bioinformatics
    经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2231345, encodeId=d5ba223134586, content=Pending大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6dd9470622, createdName=ms3000001950019838, createdTime=Thu Oct 17 13:49:49 CST 2024, time=2024-10-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2229966, encodeId=a265222996642, content=偏重的研究方向：肿瘤;药学<br>经验分享：大修只给 10 天😵‍💫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Oct 09 15:16:44 CST 2024, time=2024-10-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229785, encodeId=bcd22229e85bb, content=各位友友，这个期刊发邮件来特刊征稿，大家别信了，我投了两次，全是秒拒，特喵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Oct 08 12:52:03 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学<br>经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的 被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学<br>经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：miRNAs;cancer;Bioinformatics<br>经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省)]
    2023-03-02 ms7000002142912750 来自江苏省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：医学
    经验分享：很快接受

    4

    展开4条回复
共80条页码: 1/8页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map